Anti-Ageing Drugs

Anti-Ageing Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020-2025

  • Report ID: BMRC 450 | Number of pages: 199 | Publish Date: Jan 2020
    Status: Published | Category: Healthcare | Delivery Timeline: 48 hrs


COVID-19
To know the impact of COVID-19 On Anti-Ageing Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020-2025 Market

Request Now

Market Size Graph


The global anti-ageing drugs market is set to witness huge growth potential in the coming years owing to rising awareness among the aging population regarding the use of anti-aging products. The industry however is in its infancy stage due to lot of skepticism regarding the cellular understanding of ageing process. On the other hand, the industry is also witnessing a large amount of research and development activities with drug manufacturers showing an increased focus towards significantly decreasing the impact of ageing and ultimately increasing the lifespan.

Various recent discoveries indicating the use of pharmacology to delay and possibly improve the aging process has spurred the interest of many manufacturers. Aging is a natural process in a human life. However, such discoveries should contribute in increasing the life span of older people as well as maintain their quality of life. The introduction of such anti ageing drugs will lead to the reduction of socio-economic burden in developed countries particularly. Citing this, research and development of anti ageing drugs is on forefront in the developed countries of North America and Europe. 

The global Anti-ageing Drugs Market is witnessing a huge surge in research activities of biotechnology companies towards development of drugs to extend normal human lifespan. For instance, Elevian, Inc. is actively conducting research focused on a protein called growth differentiating factor 11 (GDF11). This protein is found to improve brain function, exercise capacity and fasten muscle repair process when introduced in old mice.  

Moreover, Elysium Health, one of the prominent players in the anti-aging market space has introduced an over the counter nutritional supplement that intends to boost one’s NAD+ levels leading to enhance longevity genes. However, clinical benefit of this supplement is not yet proven.

Increasing target population and growing influence of lifestyle industry are some of the pivotal factors boosting the market growth.

The rising ageing population acts as target market for anti-ageing drugs driving the growth of this market. According to the World Health Organization (WHO), the proportion of global population over age of 60 years is predicted to double and reach 22% by 2050 from 12% in 2015. Moreover, the growing influence of lifestyle and fashion industry has led to an increased desire among the old to stay young and healthy. Apart from this, the elevating level of beauty standards has led to boost in demand for anti-ageing drugs among all age groups. Rising investments in research and development activities leading to incessant launch of new products is anticipated to be another pivotal factor driving the anti-ageing drugs market growth during the forecast period.

North America accounted for the largest share in Anti-Ageing Drugs Market

Developed economies of U.S. and Canada are the largest revenue contributors to the global anti-ageing drugs market. This should be well justified by the high living standards, huge paying capacity and growing influence of fashion and lifestyle industry among the population. Moreover, the region houses developed infrastructure for carrying out progressive research activities aimed towards development of new anti-ageing products. These factors have collectively led to the expansion of anti-ageing drugs market in the region. Europe is set to witness similar trends as that of North America and grab the second position in the global anti-ageing drugs market. While the growing personal care industry coupled with increasing awareness regarding use of anti-ageing products in the emerging economies of China and India is expected to propel the Asia Pacific anti-ageing drugs market growth in the years to come.

Key Players in Anti-Ageing Drugs Market

Some of the major players operating in Global Anti-Ageing Drugs Market include Galderma, Sanofi, Allergan, Daewoong Pharmaceutical, MMJ PhytoTech, Revitacare, Merz Pharma, SciVision Biotech, Canbex Therapeutics, Sun Pharmaceuticals, Nu Skin, L’ORÉAL, Elysium Health Inc., and BIOTIME, INC. among others.

Global Anti-Ageing Drugs market is segmented by type, drug class, and application. The Global Anti-Ageing Drugs market by type includes injectable, oral, and topical, while based on drug class the industry is segmented into antioxidants and enzymes, serums and supplements, and stem cells. By application market segmentation includes skin, hair, muscles, age-related disorders and others.

The geographic analysis in the report spans across North America, Europe, Asia-Pacific and Rest of the World. Further, country level analysis of the Global Anti-Ageing Drugs Market includes U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, and Africa among others.

Market Segmentation: -

By Type:

  • Injectable
  • Oral
  • Topical

By Drug Class:

  • Antioxidants and enzymes
  • Serums and supplements
  • Stem cells

By Application:

  • Skin
  • Hair
  • Muscles
  • Age-related disorders
  • Others

By Region & Country:

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa


Interested in this report?

Anti-Ageing Drugs Market Share and Growth to 2025 and Analysis 2019-2025

report cover

Table of Content

Chapter 1 Global Anti-Ageing Drugs Market: Summary and Quantitative Analysis
1.1 Report Description
1.2 Global Anti-Ageing Drugs Market Revenue Overview
1.3 Global Anti-Ageing Drugs Market Revenue (USD Billion) and Growth (%) Rate, 2015- 2025

Chapter 2 Global Anti-Ageing Drugs Market: Overview and Qualitative Analysis
2.1 Executive Summary
2.2 Market Drivers
2.3 Market Restraints
2.4 Market Opportunities
2.5 Market Trends
2.6 Global Anti-Ageing Drugs Market: SWOT Analysis
2.7 Global Anti-Ageing Drugs Market: PEST Analysis
2.7 Global Anti-Ageing Drugs Market: Porter’s Five Forces Analysis
2.8 Global Anti-Ageing Drugs Market: Attractiveness Analysis
2.8.1 Global Anti-Ageing Drugs Market: Attractiveness Analysis by Type
2.8.2 Global Anti-Ageing Drugs Market: Attractiveness Analysis by Grade
2.8.3 Global Anti-Ageing Drugs Market: Attractiveness Analysis by Regional

Chapter 3 Competitive Analysis
3.1 Global Anti-Ageing Drugs Market
3.1.1 Global Anti-Ageing Drugs market Revenue (USD Billion), By Players 2018
3.1.2 Global Anti-Ageing Drugs Market Revenue Share (%), By Players 2018

Chapter 5 Global Anti-Ageing Drugs Market: By Product Type
5.1 Global Anti-Ageing Drugs Market Share (%), By Product Type, 2018
5.2 Global Anti-Ageing Drugs Market Revenue (USD Billion), By Product Type, 2015 – 2025
5.3 Global Anti-Ageing Drugs Market Revenue (USD Billion), By Retro,2015-2025
5.4 Global Anti-Ageing Drugs Market Revenue (USD Billion), 2015-2025
5.4 Global Anti-Ageing Drugs Market Revenue (USD Billion), 2015-2025
5.5 Global Anti-Ageing Drugs Market Revenue Share (%), By Product Type, 2015 – 2025
5.6 Global Anti-Ageing Drugs Market Revenue Market Share (%), By Product Type, 2015-2025

Chapter 6 Global Anti-Ageing Drugs Market: By Product Type
6.1 Global Anti-Ageing Drugs Market Share (%), By Product Type, 2018
6.2 Global Anti-Ageing Drugs Market Revenue (USD Billion), By Type, 2015 – 2025

Chapter 7 North America Anti-Ageing Drugs Market Analysis
7.1 North America Market Snapshot
7.1.1 North America Anti-Ageing Drugs Market Revenue and Growth Rate (%), 2015-2025.
7.1.2 North America Anti-Ageing Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
7.1.3 North America Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
7.1.5 North America Anti-Ageing Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025
7.1.6 North America Anti-Ageing Drugs Revenue (USD Billion) Overview, By Product Type , 2015-2025

Chapter 8 Europe Anti-Ageing Drugs Market Analysis
8.1 Europe Market Snapshot
8.1.1 Europe Anti-Ageing Drugs Market Revenue and Growth Rate (%), 2015-2025.
8.1.2 Europe Anti-Ageing Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
8.1.3 Europe Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
8.1.5 Europe Anti-Ageing Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025
8.1.6 Europe Anti-Ageing Drugs Revenue (USD Billion) Overview, By Type, 2015-2025

Chapter 9 Asia Pacific Anti-Ageing Drugs Market Analysis
9.1 Asia Pacific Market Snapshot
9.1.1 Asia Pacific Anti-Ageing Drugs Market Revenue and Growth Rate (%), 2015-2025.
9.1.2 Asia Pacific Anti-Ageing Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
9.1.3 Asia Pacific Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
9.1.5 Asia Pacific Anti-Ageing Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025
9.1.6 Asia Pacific Anti-Ageing Drugs Revenue (USD Billion) Overview, By Type, 2015-2025

Chapter 10 Latin America Anti-Ageing Drugs Market Analysis
10.1 Latin America Market Snapshot
10.1.1 Latin America Anti-Ageing Drugs Market Revenue and Growth Rate (%), 2015-2025.
10.1.2 Latin America Anti-Ageing Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
10.1.3 Latin America Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
10.1.5 Latin America Anti-Ageing Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025
10.1.6 Latin America Anti-Ageing Drugs Revenue (USD Billion) Overview, By Type, 2015-2025

Chapter 11 Middle East & Africa Anti-Ageing Drugs Market Analysis
11.1 Middle East & Africa Market Snapshot
11.1.1 Middle East & Africa Anti-Ageing Drugs Market Revenue and Growth Rate (%), 2015-2025.
11.1.2 Middle East & Africa Anti-Ageing Drugs Market Revenue (USD Billion) Overview, by Country, 2015 – 2025
11.1.3 Middle East & Africa Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
11.1.4 Middle East & Africa Anti-Ageing Drugs Revenue (USD Billion) Overview, By Product Type, 2015-2025 
11.1.5 Middle East & Africa Anti-Ageing Drugs Revenue (USD Billion) Overview, By Product Types, 2015-2025
11.1.6 Middle East & Africa Anti-Ageing Drugs Revenue (USD Billion) Overview, By Type, 2015-2025

Chapter 12 Competitive Analysis
12.1 Company 1.
12.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.1.2 Company 1. Total Company Revenue 2015-2018
12.1.3 Company 1. Total Company Revenue, By Segment of Business 2015-2018
12.1.4 Company 1. Total Company Revenue, By Region 2015-2018
12.1.5 Company 1. Global Anti-Ageing Drugs Product Category and Description
12.1.6 Company 1. Recent Activity 2015-2019
12.1.7 Main Business/Business Overview
12.1.8 Business Strategy
12.1.9 SWOT Analysis
12.2 Company 2.
12.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
12.2.2 Company 2. Total Company Revenue 2015-2018
12.2.3 Company 2. Total Company Revenue, By Segment of Business 2015-2018
12.2.4 Company 2. Total Company Revenue, By Region 2015-2018
12.2.5 Company 2. Global Anti-Ageing Drugs Product Category and Description
12.2.6 Company 2. Recent Activity 2015-2019
12.2.7 Main Business/Business Overview
12.2.8 Business Strategy
12.2.9 SWOT Analysis
12.3 Company 3
12.3.1 Business Overview
12.3.2 Company 3Market Product Category and Description & Specification
12.3.3 Main Business/Business Overview
12.3.4 Business Strategy
12.3.5 SWOT Analysis
12.4 Company 4.
12.4.1 Business Overview
12.4.2 Company 4.Company Total Company Revenue 2015-2018
12.4.3 Company 4.Company Total Company Revenue, By Segment of Business 2015-2018
12.4.4 Company 4.Company Total Company Revenue, By Region of Business 2015-2018
12.4.5 Company 4.Company Product Category, Specification and Description
12.4.6 Company 4.Company Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.4.7 Company 4.Company Main Business/Business Overview
12.4.8 Business Strategy
12.4.9 SWOT Analysis
12.5 Company 5
12.5.1 Business Overview
12.5.2 Company 5 Company Net Sales 2015-2018
12.5.3 Company 5 Company Net Sales, By Segment of Business 2011-2018
12.5.4 Company 5 Company Net Sales, By Region 2015-2018
12.5.5 Company 5 Anti-Ageing Drugs Market Product Category and Specification
12.5.6 Company 5 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.5.7 Company 5 Main Business/Business Overview
12.5.8 Business Strategy
12.5.9 SWOT Analysis
12.6 Company 6
12.6.1 Business Overview
12.6.2 Company 6 Anti-Ageing Drugs Market Product Category and Specification
12.6.3 Company 6 Recent Mergers & Acquisitions (M&A) Activity 2015-2019
12.6.4 Company 6 Main Business/Business Overview
12.6.5 Business Strategy
12.6.6 SWOT Analysis

Chapter 13 Market Research Findings & Conclusion

Chapter 14 Research Methodology
14.1 Research Process
14.2 Primary Research
14.3 Secondary Research
14.4 Market Size Estimates
14.5 Forecast Model
14.7 Who is This Report For?
14.8 USP’s of Report

List of Figures 

FIG. 1 Global Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015- 2025
FIG. 4 Global Anti-Ageing Drugs Market: Attractiveness Analysis By Product Type
FIG. 5 Global Anti-Ageing Drugs Market: Attractiveness Analysis By Type
FIG. 6 Global Anti-Ageing Drugs Market: Attractiveness Analysis by Regional
FIG. 7 Global Anti-Ageing Drugs Market
FIG. 8 Global Anti-Ageing Drugs Market Share (%), By Product Type, 2018
FIG. 9 Global Anti-Ageing Drugs Market Revenue (USD Billion), By Application, 2015-2025
FIG. 10 Global Anti-Ageing Drugs Market Revenue (USD Billion), By End Use , 2015-2025
FIG. 10 Global Anti-Ageing Drugs Market Revenue (USD Billion), By Type, 2015-2025
FIG. 11 Global Anti-Ageing Drugs Market Revenue Market Share (%), By Product Type, 2015-2025
FIG. 20 North America Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 21 North America Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 22 Europe Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 23 Europe Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 24 Asia Pacific Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 25 Asia Pacific Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 26 Latin America Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 27 Latin America Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 28 Middle East & Africa Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015-2025.
FIG. 29 Middle East & Africa Anti-Ageing Drugs Market Revenue (USD Billion) and Growth Rate (%), 2015 – 2025.
FIG. 30 Company 1. Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 31 Company 1. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 32 Company 1. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %)
FIG. 33 Company 2. Total Company Revenue 2015-2018 (USD Million)
FIG. 34 Company 2. Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 35 Company 2. Total Company Revenue, by Region 2015-2018 (USD Million, AGR %) 119
FIG. 36 Company 3 Total Company Revenue 2015-2018 (USD Million)
FIG. 37 Company 3 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 38 Company 3 Total Company Revenue, by Region of Business 2015-2018 (USD Million, AGR %)
FIG. 39 Company 4. Company Net Sales 2015-2018 (USD Million, R & D Expenses %)
FIG. 40 Company 4. Company Net Sales, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 41 Company 4. Company Net Sales, by Region 2015-2018 (USD Million, AGR %)
FIG. 42 Company 5 Total Company Revenue 2015-2018 (USD Million, R & D Expenses %)
FIG. 43 Company 5 Total Company Revenue, by Segment of Business 2015-2018 (USD Million, AGR %)
FIG. 44 Primary Research
FIG. 45 Sources of Secondary Research
FIG. 46 Forecast Model

List of Tables

TABLE 1 Global Anti-Ageing Drugs Market Overview
TABLE 2 Market Driver Impact Analysis
TABLE 3 Market Restraints Impact Analysis
TABLE 4 Global Anti-Ageing Drugs market Revenue (USD Billion), By Players2018
TABLE 5 Global Anti-Ageing Drugs market Revenue Market share (%), By Players- 2018
TABLE 6 Global Anti-Ageing Drugs Market Revenue (USD Billion), By Product Type, 2015 - 2025
TABLE 7 Global Anti-Ageing Drugs Market Revenue Share (%), By Product Type, 2015 - 2025
TABLE 8 Global Anti-Ageing Drugs Market Revenue (USD Billion), By Product Type, 2015 - 2025
TABLE 9 Global Anti-Ageing Drugs Market Revenue Share (%), By Product Type, 2015 - 2025
TABLE 10 Global Anti-Ageing Drugs Market Revenue (USD Billion), 2015 - 2025
TABLE 11 Global Anti-Ageing Drugs Market Revenue Share (%), By , 2015 - 2025
More …………...

Anti-Ageing Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020-2025

  • Full Name * :
  • Bussiness Email * :
  • Job Title :
  • Company :
  • Contact No * :
  • Country * :
  • Any Query * :
  • Captcha * :
Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Choose License Type ( Price )

Single user license, allowing one specific user access to the product.
Multi-users license, allowing up to five users access to the product.
Corporte license . Allows all employees within your organization to access product.


American Express Citi Bank Credit/Debit Card Maestro Payment Master Card PayPal Visa Wire Transfer

+44-1173181773
alan@brandessenceresearch.biz


Looking for Regional Reports?